Related references
Note: Only part of the references are listed.Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial
Joshua S. Davis et al.
CLINICAL INFECTIOUS DISEASES (2016)
Reduced In Vitro Activity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from Australia
I. J. Abbott et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
Steven Y. C. Tong et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections
J. S. Davis et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Evaluation of Vancomycin in Combination with Piperacillin-Tazobactam or Oxacillin against Clinical Methicillin-Resistant Staphylococcus aureus Isolates and Vancomycin-Intermediate S. aureus Isolates In Vitro
Thomas J. Dilworth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Evaluation of Ceftaroline, Vancomycin, Daptomycin, or Ceftaroline plus Daptomycin against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Simulated Endocardial Vegetations
Brian J. Werth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline
George Sakoulas et al.
CLINICAL THERAPEUTICS (2014)
The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA
Benjamin P. Howden et al.
INFECTION GENETICS AND EVOLUTION (2014)
Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes
Katie E. Barber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
George Sakoulas et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Comparison of the Incidence of Vancomycin-Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin-Tazobactam
Lindsey D. Burgess et al.
PHARMACOTHERAPY (2014)
Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or Cefepime
Diane M. Gomes et al.
PHARMACOTHERAPY (2014)
Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
Brian J. Werth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA
B. J. Werth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Evaluation of Ceftaroline Activity against Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate Methicillin-Resistant S-aureus Strains in an In Vitro Pharmacokinetic/Pharmacodynamic Model: Exploring the Seesaw Effect
Brian J. Werth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?
Sebastiaan J. van Hal et al.
CLINICAL INFECTIOUS DISEASES (2013)
Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the seesaw effect: Taking advantage of the back door left open?
Jessica K. Ortwine et al.
DRUG RESISTANCE UPDATES (2013)
Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus
Steven N. Leonard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
In Vitro Pharmacodynamics of Vancomycin and Cefazolin Alone and in Combination against Methicillin-Resistant Staphylococcus aureus
Mao Hagihara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Synergistic Activity of Ceftobiprole and Vancomycin in a Rat Model of Infective Endocarditis Caused by Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus
Jeffrey Fernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Efficacy of Daptomycin-Cloxacillin Combination in Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus
C. Garrigos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial Activity
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
Shrenik Mehta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Synergy between Vancomycin and Nafcillin against Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Steven N. Leonard
PLOS ONE (2012)
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial
Guy Thwaites et al.
TRIALS (2012)
Use of Antistaphylococcal β-Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
Abhay Dhand et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
Natasha E. Holmes et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Evaluation of the synergistic potential of vancomycin combined with other antimicrobial agents against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus spp strains
Livia Viganor da Silva et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2011)
Lack of Bactericidal Antagonism or Synergism In Vitro between Oxacillin and Vancomycin against Methicillin-Susceptible Strains of Staphylococcus aureus
Christian Joukhadar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides
S. Ribes et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?
Hien M. Nguyen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections
Stan Deresinski
CLINICAL INFECTIOUS DISEASES (2009)
Staphylococcus aureus Bacteraemia in a Tropical Setting: Patient Outcome and Impact of Antibiotic Resistance
Emma K. Nickerson et al.
PLOS ONE (2009)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States
R. Monina Klevens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S-aureus (MRSA) blood isolates from 2001-05
Gregory Steinkraus et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections
Lorenzo Drago et al.
BMC INFECTIOUS DISEASES (2007)
Limitations of vancomycin in the management of resistant staphylococcal infections
Marin H. Kollef
CLINICAL INFECTIOUS DISEASES (2007)
Point:: Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus
John F. Mohr et al.
CLINICAL INFECTIOUS DISEASES (2007)
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Ravindra L. Mehta et al.
CRITICAL CARE (2007)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The pharmacokinetic and pharmacodynamic properties of vancomycin
MJ Rybak
CLINICAL INFECTIOUS DISEASES (2006)
Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin
BT Tsuji et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and enterococci by FIC index and timed-kill curves
DR Snydman et al.
JOURNAL OF CHEMOTHERAPY (2005)
Synergy of daptomycin with oxacillin and other β-lactams against methicillin-resistant Staphylococcus aureus
KH Rand et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus
RP Adhikari et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis
SE Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2003)
In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis
A Lozniewski et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Vancomycin and oxacillin synergy for methicillin-resistant staphylococci
BE Domaracki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
